Physician

James N. Antezana, MD

According to 2025 Medicare claims, James Antezana, MD (NPI: 1134174436) practices general surgery in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is SOUTH CHARLOTTE GENERAL AND VASCULAR SURGERY PLLC (NPI: 1144524190; TIN: 274451494) and primary practice location at 28273-0054. Antezana is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Antezana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 275 traditional Medicare patients, billed 4,137 HCPCS/CPT codes, and received $1,925,634 in Medicare payments. The top billing code was 93925 (Ultrasound of leg arteries or artery grafts). Part D data shows 795 prescription claims across 223 beneficiaries totaling $241,220 in drug costs, led by Xarelto (Rivaroxaban). 2022 DME data shows 26 claims. Open Payments data shows 32 records totaling $6,276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,321,216 and ending at $1,925,634. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $34,272 to $241,220. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	233	2,805	$1,321,216
2016	226	2,848	$1,222,649
2017	235	2,659	$1,144,025
2018	306	3,181	$1,873,879
2019	281	3,082	$1,863,408
2020	227	2,003	$1,363,285
2021	214	2,023	$1,193,409
2022	228	1,884	$907,631
2023	251	2,767	$1,141,720
2024	275	4,137	$1,925,634

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	137	620	$34,272
2016	121	538	$23,848
2017	123	467	$5,910
2018	242	883	$29,795
2019	202	711	$59,787
2020	130	460	$71,196
2021	144	452	$93,720
2022	156	542	$118,920
2023	203	666	$200,178
2024	223	795	$241,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	22	$505
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	26	26	$19,508
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93925	Ultrasound of leg arteries or artery grafts	122	262	$167
93970	Ultrasound study of arm or leg veins with compression and maneuvers	148	222	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	210	522	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	135	237	$67
93922	Ultrasound study of arm and leg arteries	128	311	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	229	9,725	$187,435
Eliquis	Apixaban	40	1,459	$28,506
Clopidogrel	Clopidogrel Bisulfate	196	15,565	$2,112
Cilostazol	Cilostazol	36	2,190	$830
Mupirocin	Mupirocin	93	1,227	$641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$6,276	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James N. Antezana, MD?

Tedicare shows public-source Medicare data for James N. Antezana, MD (NPI 1134174436), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James N. Antezana, MD have ACO affiliation data?

James N. Antezana, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to James N. Antezana, MD?

James N. Antezana, MD is linked to SOUTH CHARLOTTE GENERAL AND VASCULAR SURGERY PLLC (billing NPI 1144524190) in the available physician profile data.

Does James N. Antezana, MD have Open Payments data?

James N. Antezana, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.